Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 7:39 pm Sale | 2025-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | ADAR1 Capital Management LLC | 2,962 0.100% | -119,862 (-97.59%) | Filing History |
| 2025-05-15 7:33 pm Purchase | 2025-03-31 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 1,502,143 9.990% | 472,146 (+45.84%) | Filing History |
| 2025-05-12 11:29 am Unchanged | 2025-05-12 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.270% | 0 (Unchanged) | Filing History |
| 2025-05-08 4:39 pm Unchanged | 2025-05-08 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.270% | 0 (Unchanged) | Filing History |
| 2025-04-28 6:43 pm Unchanged | 2025-04-24 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.290% | 0 (Unchanged) | Filing History |
| 2025-04-11 8:32 pm Purchase | 2025-04-04 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.290% | 5,390,964 (New Position) | Filing History |
| 2025-02-14 9:10 pm Purchase | 2024-12-31 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 1,095,967 9.990% | 129,669 (+13.42%) | Filing History |
| 2025-02-14 9:05 pm Sale | 2024-12-31 | 13G | ZURA BIO LTD ZURA | ADAR1 Capital Management LLC | 2,077,251 3.180% | -1,255,584 (-37.67%) | Filing History |
| 2025-02-14 9:04 pm Purchase | 2024-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ADAR1 Capital Management LLC | 6,994,246 9.990% | 6,994,246 (New Position) | Filing History |
| 2025-02-14 9:04 pm Sale | 2024-12-31 | 13G | KALA BIO, INC. KALA | ADAR1 Capital Management LLC | 298,955 4.910% | -181,476 (-37.77%) | Filing History |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | KALA BIO, INC. KALA | ADAR1 Capital Management LLC | 480,431 9.990% | 480,431 (New Position) | Filing History |
| 2024-11-14 4:48 pm Purchase | 2024-09-30 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 966,298 9.990% | 966,298 (New Position) | Filing History |
| 2024-11-14 4:47 pm Purchase | 2024-09-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | ADAR1 Capital Management LLC | 122,824 8.510% | 122,824 (New Position) | Filing History |
| 2024-11-14 4:47 pm Purchase | 2024-09-30 | 13G | ZURA BIO LTD ZURA | ADAR1 Capital Management LLC | 3,332,835 5.100% | 3,332,835 (New Position) | Filing History |
| 2024-11-14 4:46 pm Purchase | 2024-09-30 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | ADAR1 Capital Management LLC | 750,000 8.420% | 750,000 (New Position) | Filing History |
| 2024-11-14 4:45 pm Purchase | 2024-09-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 315,103 9.990% | 315,103 (New Position) | Filing History |
| 2024-11-14 4:40 pm Purchase | 2024-09-30 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 1,029,997 9.990% | 70,426 (+7.34%) | Filing History |
| 2024-08-01 08:00 am Purchase | 2024-07-24 | 13G | PIERIS PHARMACEUTICALS INC PIRS | ADAR1 Capital Management LLC | 138,641 10.500% | 138,641 (New Position) | Filing History |
| 2024-07-10 9:10 pm Purchase | 2024-06-28 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 959,571 10.200% | 959,571 (New Position) | Filing History |